Human endogenous retrovirus profiling reveals heterogenous expression in cutaneous melanoma
Frontiers in Oncology · 26.03.2026 · 16
DOI: 10.3389/fonc.2026.1708501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 26.03.2026. Verfasst von Tongyi Fei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Cutaneous melanoma (CM) is a cancer of the pigment-producing melanocytes of the skin. Advances in treatment with immune checkpoint inhibitors (ICI) have greatly improved the outcomes, although not all patients with CM respond to ICI. Emerging evidence shows that ICI responsiveness is correlated with the expression of certain human endogenous retroviruses (HERVs). We aimed to investigate the relationships between HERV expression and outcomes in patients with CM.
Methods
We characterized HERV expression from 330 patients with primary or metastatic CM using Telescope, a computational software package that calculates the expression of HERV loci from bulk RNA sequencing datasets.
Results
We found that HERVs expression differed between primary and metastatic CM. Using HERV expression alone, three subtypes of metastatic CM had distinct survival outcomes. Among the differentially expressed HERV loci in metastatic and treatment non-responders, we identified HERV-FRD which has the potential to produce the endogenous retrovirus group V Env polyprotein (syncytin-2) precursor.
Conclusion
Our analyses demonstrate the unique features of HERV expression in CM metastases and in ICI responsiveness. These exploratory findings identify modulated HERVs in CM, and further studies should be developed to determine whether HERV expression has any predictive or clinical utility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
- Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- Northwell Health, New Hyde Park, NY, United States.
- Feinstein Institutes for Medical Research, Institute of Translational Research, Manhasset, NY, United States.
- Zucker School of Medicine at Hofstra/Northwell-Hofstra University, Hempstead, NY, United States.
- Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Förderung
- NCI NIH HHS
Zitieren
APA
Fei, T., Singh, B., Dopkins, N., Marston, J. L., Francis, J. H., Nixon, D. F., Shoushtari, A. N., & Bendall, M. L. (2026). Human endogenous retrovirus profiling reveals heterogenous expression in cutaneous melanoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1708501
Vancouver
Fei T, Singh B, Dopkins N, Marston JL, Francis JH, Nixon DF, et al. Human endogenous retrovirus profiling reveals heterogenous expression in cutaneous melanoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1708501
BibTeX
@article{Fei2026,
author = {Fei, Tongyi and Singh, Bhavya and Dopkins, Nicholas and Marston, Jez L and Francis, Jasmine H and Nixon, Douglas F and Shoushtari, Alexander N and Bendall, Matthew L},
title = {Human endogenous retrovirus profiling reveals heterogenous expression in cutaneous melanoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1708501}
}
EUVIMED